Graham C, Borker R, Oppe M, Groot CD, Barber B, Brogan A, Amado R. Cost-effectiveness of panitumumab plus best supportive care compared with best supportive care alone in chemorefractory metastatic colorectal cancer patients with wild-type KRAS tumor status in the Netherlands. Poster presented at the European Society for Medical Oncology; September 12, 2008. Stockholm, Sweden. [abstract] Ann Oncol. 2008 Sep 12; 19:134.